fig9

CDK4/6 and BET inhibitors synergistically suppress pancreatic tumor growth and epithelial-to-mesenchymal transition by regulating the GSK3β-mediated Wnt/β-catenin pathway

Figure 9. Mechanism effects of combined JQ1 and PD-0332991 treatment on EMT in pancreatic 60400 cells. (A) qPCR analysis of EMT-related gene expression in 60400 cells treated with PD-0332991, with or without JQ1; (B) qPCR analysis of invasion-associated gene expression in 60400 cells treated with PD-0332991, with or without JQ1; (C) Western blot analysis of EMT markers and Wnt/β-catenin signaling components following treatment with PD-0332991, JQ1, or their combination in 60400 cells; (D) Western blot analysis of TGFβ/Smad pathway inhibition by JQ1 in 60400 cells. Data are presented as mean ± SEM from three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; ns: not significant. EMT: Epithelial-to-mesenchymal transition; qPCR: quantitative polymerase chain reaction; SEM: standard error of the mean.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/